Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Depreciation and Depletion (2019 - 2025)

Arcadia Biosciences (RKDA) has disclosed Depreciation and Depletion for 7 consecutive years, with $2000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation and Depletion fell 71.43% year-over-year to $2000.0, compared with a TTM value of $13000.0 through Sep 2025, up 131.71%, and an annual FY2024 reading of $58000.0, down 47.75% over the prior year.
  • Depreciation and Depletion was $2000.0 for Q3 2025 at Arcadia Biosciences, down from $15000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $253000.0 in Q3 2021 and bottomed at -$116000.0 in Q4 2023.
  • Average Depreciation and Depletion over 5 years is $78368.4, with a median of $71000.0 recorded in 2023.
  • The sharpest move saw Depreciation and Depletion crashed 236.47% in 2023, then soared 254.55% in 2024.
  • Year by year, Depreciation and Depletion stood at $192000.0 in 2021, then plummeted by 55.73% to $85000.0 in 2022, then plummeted by 236.47% to -$116000.0 in 2023, then surged by 85.34% to -$17000.0 in 2024, then surged by 111.76% to $2000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for RKDA at $2000.0 in Q3 2025, $15000.0 in Q2 2025, and $13000.0 in Q1 2025.